Ansa Biotechnologies
PrivateLast Round
Series B
Oct 1, 2025
Total Funding Raised
$132.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ansa Biotechnologies is a biotechnology company that provides enzymatic DNA synthesis services to accelerate biological research and synthetic biology innovation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ansa Biotechnologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Ansa Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 1, 2025 | ||||
| Series A | Apr 11, 2022 | ||||
| Grant | Apr 15, 2021 | ||||
| Seed | Sep 14, 2020 | ||||
| Pre Seed | Dec 1, 2018 |
Key People
Founding team and executive leadership
Ansa Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Seed, Series A |
| RA Capital Management | Series A |
| Fall Line Capital | Series B |
| Codon Capital | Series A |
| PEAK6 Strategic Capital | Series A |
| Altitude Life Science Ventures | Series A, Series B |
| Carbon Silicon Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Will present at SynBioBeta 2026 conference in San Jose, CA.
- Mar 31, 2026
Matthias Arenskötter appointed as the new COO.
Ansa Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ansa Biotechnologies's valuation, stock price, and market status.